SeqOnce BioSciences
Pasadena, US · Founded 2015 · Delaware corporation · 1 known investors
Founders & leadership
CA
Christopher AngermayerExecutive
MG
Michael GiardelloNamed on SEC filing
Board
JD
Joseph DunhamBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 2 rounds · 2018–2024
▶$881.8KraisedNov 2024 · 4 investors · BiotechnologyRule 506(b)
▶$881.8KraisedNov 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher AngermayerExecutive Officer, Director
- Joseph DunhamDirector
- Offering amount
- $881.8K
- Amount sold
- $881.8K
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedApr 2018 · 12 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2018 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael GiardelloDirector
- Christopher AngermayerExecutive Officer, Director
- Joseph DunhamDirector
- Offering amount
- $1.2M
- Amount sold
- $1M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are SeqOnce BioSciences's investors?
- SeqOnce BioSciences's investors include Design Accelerator.
- How much funding has SeqOnce BioSciences raised?
- SeqOnce BioSciences has disclosed $1.9M raised across 2 rounds.
- Where is SeqOnce BioSciences headquartered?
- SeqOnce BioSciences is headquartered in Pasadena, US.